With the state set to make medical marijuana available within weeks, two Maryland companies have formed a partnership to study how well vapor-inhalation devices work for patients.
Tag Archives: companies
A subsidiary of the New York Stock Exchange launches trading on Dec. 26 for its first-ever marijuana fund, a major step for an industry that’s struggled to access mainstream U.S. financial instruments, even as Canadian markets have kicked off marijuana investment.
In the business of medicinal marijuana, there are strains for almost anything that ails you. So far, though, female entrepreneurs have yet to find a variety that addresses a painful side effect of the booming legal pot industry: sexism.
At one point, MassRoots was flying high, raising millions of dollars from investors and attempting to become the first cannabis company listed on the Nasdaq.
Manitoba’s the latest province to unveil its plan for marijuana sales and distribution, releasing details Tuesday on how the new industry will operate.
Colorado cannabis companies have found it is hard for them to be charitable. Nonprofits often turn away pot profits for fear of losing federal grant money.
Marijuana stocks were down sharply in Tuesday’s trading as Toronto Stock Exchange operator TMX Group Limited suggested the exchange is going to start cracking down on marijuana producers engaging in illegal activities south of the border.
I had a chance to interview one of the cannabis industry movers, someone who has been involved in this industry for quite some time. She has co-founded several companies, had her hands in all different kinds of areas during these start-ups and finally through all of that has found her one true passion in the cannabis world. She is an cannapreneur that radiates energy and excitement!
Canada’s TMX Group Ltd (X.TO), operator of the Toronto Stock Exchange, said on Monday that it might delist stocks of marijuana companies with interests in the United States, where their operations are illegal under federal law.
Despite strong opposition from former White House Press Secretary Sean Spicer and Attorney General Jeff Sessions, and the overall limitations imposed by federal illegality in the U.S., 2017 is shaping up to be a great year for the North American cannabis industry.
Baltimore judge ruled Wednesday that a case that could disrupt Maryland’s fledgling medical marijuana industry should proceed to trial.
Commuters might catch a glimpse of the future out their car windows on Monday: the first Massachusetts billboard ads for a marijuana dispensary.
Bank of Montreal and Toronto-Dominion Bank are emerging as the banks of choice for Canada’s burgeoning marijuana industry, even as some lenders shun the sector.
Marijuana stock investors are going to have to keep their eyes on the following two critical data points for each and every marijuana stock they’re considering buying, or that they already own.
With recreational marijuana set to become legal in California in just a few months, this year’s Cannabis World Congress and Business Expo was bigger than ever.
Charity organizations are reluctant to take donations from cannabis companies, even if the state has legalized the industry. Organa Brands learned this the hard way.
At long last, Maryland’s first legal marijuana crop is growing. With 19 companies cleared to grow, process and sell the plant, the seeds of the medical marijuana program have literally been planted, four years after the state legalized cannabis for medical use.
It seems as though news of recalls related to specific batches of bad marijuana from licensed Canadian producers has been coming in more frequently than marijuana investors and consumers would like to see.
Despite missing a key state deadline earlier this month, three more medical marijuana growers won final licenses on Monday to cultivate the drug.
As more states legalize adult use marijuana, hemp CBD makers will find that they will need to make marijuana-derived products too if they want to succeed.
Medical cannabis companies and investors are calling on Gov. Greg Abbott’s office and the Department of Public Safety to approve more dispensary licenses beyond the three given provisional approval in May.
Any move by the Toronto Stock Exchange owner to stop settling trades for marijuana companies with U.S. operations would undermine the market’s regulatory system, according to one Canadian pot company.
There has been a lot of news in the marijuana industry this year. The medical marijuana industry exploded, and many new companies came to market in a frenzy, which reminded investors of the exciting technology bubble.
The legal sale of marijuana in Uruguayan pharmacies is facing challenges as banks refuse to deal with companies linked to the drug in order to follow international financial laws.
Canada’s TMX Group Ltd (X.TO) is seeking guidance from the country’s securities regulators, it said on Thursday, as it weighs how to deal with marijuana companies listed in Canada with interests in the United States, where the business remains federally illegal.
By all accounts, Eilon Bdil has no personal interest in marijuana. But as the business manager of Kibbutz Elifaz, he’s a big believer in the herb. Bdil sees medical marijuana as a unique opportunity to revive his remote Negev community.
Future medical marijuana growers and sellers in the Natural State can’t take their money to the bank, for now, that is. After doing his homework, the state lawmaker who crafted the new cannabis laws has learned more money, more problems when it comes to doing business without banking assistance.
If you look around, chances are you won’t find many marijuana stocks struggling. But there’s always an outlier — and for the marijuana industry that’s drugmaker Insys Therapeutics.
Maryland’s beleaguered medical marijuana industry faces a critical deadline Monday, when companies the state has selected to grow the plant are required to be operational.
TMX Group Ltd’s CEO on Thursday brushed off signs that the grip of Canada’s dominant stock exchange operator on overall trading volumes was slipping, saying recent market share losses were mostly due to its rejection of certain listings.
People growing their own marijuana is a significant concern to Big Pharma. As state legalization of cannabis-derivatives spreads, the drug companies contemplating the potential of medical marijuana see a threat from both homegrown and professionally harvested medical-grade marijuana.
For many weed stocks, the summer of 2017 hasn’t been what you’d call a scorcher. However, three marijuana stocks have sizzled this summer.
Identifying companies in great financial health is important when investing in an industry like marijuana. That being said, the Canadian marijuana stocks on our list all have current ratios of at least 10x, and debt to equity ratios under 20%.
Recreational marijuana is now legal in Nevada — but the rollout isn’t exactly going according to plan. Marijuana producers are allowed to take every step involved in bringing cannabis from the soil to the store, except for one: distribution. That means vertically integrated companies have to hire third-party distributors just to move marijuana down their own hallway.
Although the hype has worn off when it comes to Canadian marijuana companies, major growth prospects still exist in this newly emerging industry.
With excitement bubbling over the growth potential in the marijuana stock market, investors are keen on which pot stocks are the best to ride that wave of hype into comfortable returns.
Companies in the final running for licenses to grow medical marijuana should be able to defend their multimillion-dollar investments against a legal challenge over how those finalists were picked, an attorney argued Thursday in court.
Marijuana companies could actually help the communities that host them. And we’re not just talking about tax revenue. Legal marijuana distributors and dispensaries can – and likely will – directly improve the quality of life in the communities that they serve.
Over the trailing-12-month period through July 15, the average marijuana stock with a market cap in excess of $200 million — a dozen stocks in total, which excluded MedReleaf because it just went public a month ago — was up by 332%.
You don’t have to be Nostradamus to successfully predict that more states will legalize marijuana — whether for medicinal use only or for recreational use.
In total, four marijuana stocks jumped higher by at least 10% last week. Let’s take a brief look at some of these moves.
Here, CEOs and cannabis executives share their advice on using social media to reach customers, suppliers, investors and the press.
The chief executive of licensed marijuana producer Aphria Inc. is calling on his competitors to disclose and reduce their production costs well in advance of the coming legal recreational market.
There have been two interesting developments with marijuana producers Aurora Cannabis Inc. (TSXV:ACB) and Aphria Inc. (TSX:APH).
Insys Therapeutics is one of several biotechs developing cannabinoid drugs. Unlike most of these other companies, though, Insys has already won regulatory approval for its first cannabinoid — Syndros.
Here’s why Scotts Miracle-Gro Company, GW Pharmaceuticals, and Canopy Growth Corporation are three stocks to buy if you’ve never bought a cannabis stock.
Mexican medical marijuana businesses and their investors will have a long time to wait before seeing profits from the newly legalized industry.
Cannabis startups among other entrepreneurs are receiving a big platform to represent the emerging marijuana industry at this year’s San Diego Startup Week.
On Tuesday, June 20, 2017, Pennsylvania’s Department of Health is to announce which companies are the first to receive medical marijuana permits.
The first cannabis stock ETF of its kind, the Horizons Marijuana Life Sciences Index ETF allows investors to own more than a dozen pot stocks through a single investment fund. Today, however, is a different story.